York Medical brings Cuban research to the west
This article was originally published in Clinica
The Canadian licensing and development company York Medical will invest Can$7.5 million ($5.4 million) this year on bringing to western markets medical devices and diagnostic tests developed in Cuba. Part of the money will be spent on Cuban, Canadian and possibly European trials of the products, which include a urine infection and antibody susceptibility device and a cancer diagnostic test.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.